Related by context. Frequent words. (Click for all words.) 75 Kenya Malawi Mozambique 69 Gabon Ghana 65 Senegal Tanzania 62 Burkina Faso Cameroon 61 Swaziland Tanzania 61 Cape Verde Guinea Bissau 60 Mali Benin 59 Senegal Sierra Leone 59 Cameroon Gabon 59 Niger Senegal 59 Mali Mozambique 58 Congo Equatorial Guinea 58 Burkina Faso Niger 58 Guinea Guinea Bissau 57 Gabon Equatorial Guinea 57 Benin Cameroon 57 Swaziland Zambia 57 Mali Senegal 57 Namibia Swaziland 56 Mozambique Malawi 56 Congo Gabon 56 Mauritania Niger 55 Mozambique Tanzania 55 Algeria Angola 55 Benin Togo 55 Benin Burkina Faso 54 Tanzania Uganda 54 Cameroon Cote d' 54 Madagascar Malawi 54 Madagascar Mauritius 54 Burkina Faso Chad 54 Lesotho Swaziland 54 Benin Botswana 54 D' SOUZA KARKALA CHAD 53 Mozambique Namibia 53 Brunei Darussalam Cambodia 53 Straziuso reported 53 Botswana Mozambique 53 Samoa Solomon Islands 53 APA Abuja 52 MKC# 52 Colombia Costa Rica 52 Senegal Mali 52 dose escalation clinical 52 Brunei Cambodia Laos 52 PROFILE COUNTRY 51 Zambia Mozambique 51 Phase Ib clinical 51 Phase 2b clinical trials 51 Guinea Solomon Islands 51 Dominican Republic Ecuador 51 phenylalanine ammonia lyase 51 APA Lagos 50 Maniema provinces 50 Malawi Mozambique 50 Tanzania Rwanda 50 Aruba Barbados 50 HPTN 50 Segala gold 50 phase IIa clinical 50 Phase IIa trials 50 blinded placebo controlled 50 SAR# [004] 50 phase IIa 50 phase IIb clinical 50 El Salvador Honduras Nicaragua 49 Diamyd ® 49 Burkina Faso Mali 49 Phase IIa clinical trials 49 Bostwana 49 Phase 1b clinical 49 Mali Burkina Faso 49 By MICHAEL MORRISSEY 49 Luxembourg Malta 49 By Tony Edike 49 Barbados Belize 49 HIV uninfected 49 Djibouti Ethiopia 49 CONAKRY Reuters 49 Phase Ib II 49 SUCCEED trial 49 Prostate Lung Colorectal 49 ;) COUNTRY 49 phase IIb 48 dose pharmacokinetic 48 Tanzania Mozambique 48 Mauritania Morocco 48 Macedonia Moldova 48 Benin Bolivia 48 oral insulin Generex 48 Violence mars 48 Mauritania Mali 48 Phase Ia 48 El Salvador Estonia 48 Phase 1a 48 By Rob Ollikainen 48 multicenter clinical 48 Slovakia Slovenia 48 Phase IIb trials 48 pulmonology portfolio 48 By Gilbert Wandera